Next Article in Journal
Agomelatine, a Melatonin-Derived Drug, as a New Strategy for the Treatment of Colorectal Cancer
Next Article in Special Issue
Reactive Sulfur Species Omics Analysis in the Brain Tissue of the 5xFAD Mouse Model of Alzheimer’s Disease
Previous Article in Journal
Combination Therapy of Radiation and Hyperthermia, Focusing on the Synergistic Anti-Cancer Effects and Research Trends
Previous Article in Special Issue
Rhodanese-Fold Containing Proteins in Humans: Not Just Key Players in Sulfur Trafficking
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Bioavailability of Organosulfur Compounds after the Ingestion of Black Garlic by Healthy Humans

by
Alicia Moreno-Ortega
1,2,*,
Gema Pereira-Caro
1,2,
Iziar A. Ludwig
3,†,
María-José Motilva
3,‡ and
José Manuel Moreno-Rojas
1,2,*
1
Department of Agroindustry and Food Quality, Andalusian Institute of Agricultural and Fisheries Research and Training (IFAPA), Alameda del Obispo, Avda. Menéndez-Pidal, 14004 Córdoba, Spain
2
Foods for Health Group, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), 14004 Córdoba, Spain
3
Agrotecnio Center, XaRTA-TPV, Food Technology Department, Escola Tècnica Superior d’Enginyeria Agrària, University of Lleida, Avda. Alcalde Rovira Roure 191, 25198 Catalonia, Spain
*
Authors to whom correspondence should be addressed.
Current address: Departamento de Ciencias de la Alimentación y Fisiología, Facultad de Farmacia y Nutrición, Universidad de Navarra, 31008 Pamplona, Spain.
Current address: Instituto de Ciencias de la Vid y del Vino (ICVV) (Consejo Superior de Investigaciones Científicas-CSIC, Gobierno de La Rioja, UR), Finca “La Grajera”, Carretera de Burgos km 6, 26007 La Rioja, Spain.
Antioxidants 2023, 12(4), 925; https://doi.org/10.3390/antiox12040925
Submission received: 13 March 2023 / Revised: 3 April 2023 / Accepted: 11 April 2023 / Published: 13 April 2023

Abstract

:
The consumption of black garlic has been related to a decreased risk of many human diseases due to the presence of phytochemicals such as organosulfur compounds (OSCs). However, information on the metabolization of these compounds in humans is limited. By means of ultra-high-performance liquid chromatography coupled with high-resolution mass spectrometry (UHPLC-HRMS), this study aims to determine the OSCs and their metabolites excreted in urine 24 h after an acute intake of 20 g of black garlic by healthy humans. Thirty-three OSCs were identified and quantified, methiin (17,954 ± 6040 nmol), isoalliin (15,001 ± 9241 nmol), S-(2-carboxypropyl)-L-cysteine (8804 ± 7220 nmol) and S-propyl-L-cysteine (deoxypropiin) (7035 ± 1392 nmol) being the main ones. Also detected were the metabolites N-acetyl-S-allyl-L-cysteine (NASAC), N-acetyl-S-allyl-L-cysteine sulfoxide (NASACS) and N-acetyl-S-(2-carboxypropyl)-L-cysteine (NACPC), derived from S-allyl-L-cysteine (SAC), alliin and S-(2-carboxypropyl)-L-cysteine, respectively. These compounds are potentially N-acetylated in the liver and kidney. The total excretion of OSCs 24 h after the ingestion of black garlic was 64,312 ± 26,584 nmol. A tentative metabolic pathway has been proposed for OSCs in humans.

Graphical Abstract

1. Introduction

Garlic (Allium sativum L.) is a basic ingredient greatly appreciated in the world’s cuisines for its organoleptic characteristics and the health properties associated with its consumption [1]. In this sense, regular consumption of garlic has been related to a protective effect against diseases such as colorectal, lung, gastric and bladder cancer by regulating the metabolism of carcinogenic substances, inducing apoptosis or inhibition of the proliferation of cancer cells, among other mechanisms [2,3,4].
Black garlic, a garlic-derived product, has generated growing interest in recent years for its organoleptic qualities and physical and chemical characteristics. It is obtained by subjecting fresh garlic to thermal processing (70–80 °C) under controlled humidity conditions for 1–3 months [5,6,7], which induces chemical reactions in garlic, such as enzymatic browning and the Maillard reaction. This elaboration process results in a final product with a brownish colour, sweeter taste, softer texture and low pungency [8,9]. In addition, compositional changes are produced, with S-allyl-L-cysteine (SAC) being the predominant organosulfur compound in black garlic [10]. The described changes in the profile of phytochemical compounds during the processing of black garlic have attracted scientific interest, leading to multiple studies aimed at assessing the potential health effects of the regular consumption of black garlic [11,12,13,14]. Black garlic consumption has been associated with a decrease in blood pressure and total plasma cholesterol, both of which are risk factors for cardiovascular disease [15,16,17,18]. Similarly, the consumption of this product has been related to a protective effect against other medical conditions such as neurodegenerative, digestive or renal diseases [12,19,20,21]. These health properties associated with its consumption are mainly due to the presence of compounds with recognised bioactivity, particularly organosulfur compounds [11]. However, the mechanisms by which organosulfur compounds in black garlic may exert these positive effects on health need to be further elucidated. It is necessary to know their metabolism and bioavailability in order to gain a deeper understanding of their bioactive potential.
Previous in vitro studies have provided information on the bioaccessibility of phytochemical compounds in black garlic, as well as on the evolution of these compounds during fermentation at the colonic level [22]. Regarding the bioavailability of organosulfur compounds, some studies have been carried out in fresh garlic, but assessing mainly those of a volatile nature [23,24,25,26,27]. Furthermore, the bioavailability of isolated organosulfur compounds in black garlic has been evaluated, such as the excretion of SAC and its N-acetylated form in the urine of rats, mice and dogs, and the metabolization of cycloalliin in rats [28,29]. However, to the best of our knowledge, there are no studies evaluating the bioavailability of organosulfur compounds after ingestion of black garlic by humans.
Based on these observations, the aim of the present study was to identify and quantify the organosulfur compounds excreted in urine 24 h after the acute intake of 20 g of black garlic in humans. To study the organosulfur biological metabolites, a targeted chromatographic approach based on ultra-high performance liquid chromatography coupled with high-resolution mass spectrometry (UHPLC-HRMS) was used.

2. Materials and Methods

2.1. Chemicals

The reference standard compounds including S-allyl-L-cysteine sulfoxide (alliin) and S-allyl-L-cysteine (SAC) were purchased from Sigma-Aldrich (Madrid, Spain). Ammonium acetate, ammonium formate and ethanol were obtained from Sigma-Aldrich. Acetonitrile, methanol and water were of LC-MS grade.

2.2. Study Design

Twelve healthy volunteers (seven females and five males, mean age 29.0 ± 8.9 years) with a body mass index (BMI) of 23.5 ± 2.2 kg/m2 (mean ± SD) participated in this study. Exclusion criteria were pregnancy or lactation, drug allergies, any chronic medication and any antibiotic treatment during the 6 months prior to the study. Written informed consent was provided by all participants. The study protocol was approved by the Ethical Committee of the Human Clinical Research Unit at the Arnau Vilanova University Hospital, Lleida, Spain (Approval Number: CEiC-1790).
Before attending the clinic, participants were asked to follow a diet free of organosulfur compounds for two days by avoiding allium vegetables. On the morning of the feeding trial, the volunteers brought their 12 h overnight urine (basal) and were invited to eat a portion of 20 g of black garlic after fasting overnight and to continue with the organosulfur-free diet that day and until the next morning, when the last urine sample was collected. Urine samples were obtained at interval times of 0–2, 2–4, 4–8 and 8–24 h after the black garlic intake. The total volume of each sample was recorded before storing the aliquots (2 mL) at −80 °C until the chromatographic analysis.

2.3. Processing of Urine Samples

The urine samples were defrosted, vortexed and centrifuged at 15,000 rpm for 10 min at 4 °C and the supernatant was collected and stored at −80 °C until UHPLC-HRMS analysis. Each sample was prepared in duplicate.

2.4. Chromatographic Analysis of Organosulfur Compounds in Urine Samples

Aliquots of human urine samples were analysed using a UHPLC-PDA-MS mass spectrometer system (Thermo Scientific, San José, CA, USA) comprising a UHPLC pump, a PDA detector scanning from 200 to 600 nm and an autosampler operating at 4 °C (Dionex Ultimate 3000 RS, Thermo Corporation, San José, CA, USA). The chromatographic conditions were previously described by Moreno-Rojas et al. (2018) [30]. Briefly, organosulfur compounds were separated on a 2.1 × 150 mm ACQUITY UPLC 1.7 μm BEH amide column (equipped with an ACQUITY UPLC BEH amide 1.7 μm van-guard pre-column) (Waters, Spain), which was maintained at 35 °C and eluted at a flow rate of 0.4 mL/min with a 20 min gradient using two mobile phases: A: deionized water with 5 mM of ammonium acetate, 5 mM ammonium formate and 1% formic acid; and B: acetonitrile. The gradient started with 5% of A rising to 46% in 13 min and finally returning to 5% of A and was maintained for 4 min to equilibrate the column.
After passing through the flow cell of the PDA detector, the column eluate was directed to an Exactive Orbitrap mass spectrometer (Thermo Scientific, San José, CA, USA) fitted with a Heated Electrospray Ionization Probe (HESI) operating in positive ionization mode for the determination of organosulfur compounds [30]. Data acquisition and processing were carried out using the Xcalibur 3.0 software (Thermo Scientific, San José, CA, USA).
The organosulfur compounds in the human urine samples were identified by comparing the exact mass and the retention time with available standards. In the absence of standards, compounds were tentatively identified by comparing the exact theoretical mass of the molecular ion with the measured accurate mass of the molecular ion and searching against metabolite databases, including Metlin, Human Metabolome DataBase (HMDB) and more general chemical databases, such as PubChem and ChemSpider. The organosulfur compounds were quantified by selecting the exact theoretical mass of the molecular ion by reference to standard curves, obtaining a linear regression analysis with R2 values of >0.998 (n = 6) and an equation of the line with a slope of 427,961 and an intersection of −169,143 for the alliin, and with a slope of 869,774 and an intersection of −232,084 for the SAC. The detection and quantification limits were 0.03 and 0.1 ng/μL, respectively. In the absence of reference compounds, they were tentatively quantified by reference to the calibration curve of a closely related parent compound.

2.5. Statistical Analysis

A one-way ANOVA was carried out using R software (v.3.6.3., R Core Team, Vienna, Austria) to determine the overall differences between the human urine samples at different interval times after the intake of black garlic If significance was detected, a Fisher’s LSD post hoc test was then performed to compare the different interval times. A p-value < 0.05 was considered statistically significant. In addition, a Pearson correlation (p < 0.05) analysis was performed by the software SIMCA v. 17 (Umetrics, Umea, Sweden).

3. Results and Discussion

3.1. Characterisation of Organosulfur Compounds in Black Garlic

The UHPLC-HRMS analysis of the black garlic fed to the volunteers revealed the presence of twenty organosulfur compounds, in agreement with our previous study [10] (Table 1). A total of 510 µmol of organosulfur compounds was present in the 20 g of black garlic ingested by the volunteers, of which 187 µmol corresponded to γ-glutamyl-S-alk(en)yl-L-cysteine derivatives (≈37% of the total organosulfur content) and 323 µmol to S-alk(en)yl-L-cysteine derivatives (≈63% of the total). Particularly, the compounds S-allyl-L-cysteine (SAC) (154 µmol), alliin (112 µmol), γ-glutamyl-S-allyl-L-cysteine (GSAC) (87.9 µmol) and γ-glutamyl-S-allyl-L-cysteine sulfoxide (GSACS) (69.0 µmol) were the main organosulfur compounds determined in 20 g of black garlic, accounting for 83% of the total organosulfur content. These were followed by S-allylsulfenic acid, γ-glutamyl-S-allylthio-L-cysteine and methionine sulfoxide, with 18.70, 10.04 and 10.08 µmol, respectively. Small quantities of other organosulfur compounds, such as S-allylmercapto-L-cysteine (8.16 µmol), γ-glutamyl-S-methyl-L-cysteine sulfoxide (7.60 µmol), S-(2-carboxypropyl)-L-cysteine-glycine (5.2 µmol) and methiin (4.86 µmol) were also present. According to these data, Ríos-Ríos et al. (2019) [8] also reported that SAC and alliin were the main organosulfur compounds found in black garlic. SAC is mainly produced by the action of γ-glutamyl transpeptidase (γ-GTP) hydrolysing GSAC [31]. While alliin, one of the major compounds in fresh garlic, is hydrolysed by alliinase enzymes, its content in black garlic remains high as alliinase enzymes are usually inactivated during the processing of black garlic [32,33]. Figure 1 shows the chemical structures of the main organosulfur compounds found in black garlic.

3.2. Identification and Quantification of Organosulfur Compounds and their Metabolites in Urine

After the acute ingestion of 20 g of black garlic by the 12 volunteers, urine collected over 24 h was analysed by HPLC-HRMS, and thirty-three organosulfur compounds were identified. Details of the retention time, chemical formula, experimental mass and identification are presented in Table 2, and their chromatograms in Figures S1 and S2. Of the 33 compounds identified in urine, 12 were GSAk derivatives and 21 were SAk derivatives. Table 3 shows the urinary excretion of the organosulfur compounds determined 0–24 h after black garlic consumption. None of these compounds were found in urine 12 h prior to the intake of black garlic. Moreover, except for two GSAk derivatives (γ-glutamyl-S-(2-carboxyethyl)-L-cysteine-glycine, γ-glutamyl-S-allylthio-L-cysteine) and four SAk derivatives (deoxymethiin, S-allylmercapto-L-cysteine, S-propylmercapto-L-cysteine and S-allylsulfenic acid) that were not detected in the urine, the remaining parent organosulfur compounds present in black garlic were detected in the urine after the ingestion of this product. The total urine excretion of organosulfur compounds 0–24 h after the ingestion of black garlic was 64.312 ± 26.584 nmol, equivalent to 12.9% of the 498.8 µmol of organosulfur compounds ingested in the 20 g of black garlic (Table 3), with 97.3% of these being SAk derivatives and 2.7% GSAk derivatives. The bioavailability of isolated compounds characteristic of garlic, such as SAC, has been evaluated previously by other authors, obtaining bioavailability percentages between 87 and 103% [28]. However, a low bioavailability of garlic OSCs, such as allicin, has also been reported, probably because they are bound by other compounds such as proteins or fatty acids [34,35]. The low percentage of organosulfur compounds excreted in urine in the present study might also be due to the formation of intermediate metabolites and/or volatile compounds which could not be determined by targeted chromatography [27].
The main organosulfur compounds determined in the human urine were methiin (17,953 ± 6040 nmol), isoalliin (15,001 ± 9241 nmol), S-(2-carboxypropyl)-L-cysteine (8804 ± 7220 nmol) and S-propyl-L-cysteine (deoxypropiin) (7035 ± 1392 nmol), accounting for 75.9% of the total organosulfur compounds excreted after the intake of black garlic. A substantial amount of SAC (2991 ± 1059 nmol), tran-S-(1-propenyl)-L-cysteine (S1PC) (3911 ± 987 nmol), methionine sulfoxide (2221 ± 343 nmol) and alliin (1383 ± 1035 nmol) were also quantified. These results are in keeping with previous studies on black garlic, where alliin and SAC were detected after simulated gastrointestinal digestion, and methionine sulfoxide, SAC and propiin were detected after colonic fermentation in vitro [10,22]. Regarding the high concentration of isoalliin quantified, several studies have reported that during both the gastrointestinal digestion and biological metabolism of these compounds, isomerization reactions may take place, possibly resulting in an increased concentration of isoalliin derived from alliin metabolism [36,37,38].
Regarding the total organosulfur compounds, 59% were excreted between 8 and 24 h after the ingestion of black garlic, which likely means that the absorption of these compounds mainly occurs at the level of the large intestine (Figure 2).
Among the organosulfur compounds detected in the 24 h urine, N-acetyl-S-allyl-L-cysteine (NASAC), N-acetyl-S-allyl-L-cysteine sulfoxide (NASACS) and N-acetyl-S-(2-carboxypropyl)-L-cysteine (NACPC) are the N-acetylated derivatives of alliin, SAC and S-(2-carboxypropyl)-L-cysteine, respectively. NASAC and NASACS have previously been described as urinary biomarkers of garlic consumption and are considered to be metabolites of SAC. This was observed by Nagae et al. [28], who administered SAC orally and intravenously to rats, mice and dogs and subsequently determined the concentration of this compound and its metabolites (NASAC and NASACS) in plasma, urine, bile and different organs. Similarly, a study by Verhagen et al. [39] in humans detected NASAC in the urine of volunteers with a garlic-supplemented diet, but not in the urine of the control diet volunteers. Different studies have revealed a complex metabolism of the organosulfur compounds in garlic. Amano et al. [40] showed that N-acetylation of these compounds occurred in the liver and kidney by amino acid transporters located in the intestinal lumen of mammalian species [41,42]. In this sense, they evaluated the N-acetylation activity of the liver and kidney of rats and dogs, observing that N-acetylation occurred to a greater extent in rats, while in dogs, the kidney showed significantly higher NASACS deacetylation activity than N-acetylation. The results obtained in our study suggest that significant deacetylation activity can also be produced in the human liver and kidney, since the concentration of SAC (2991 ± 1059 nmol) found in the urine after 24 h was significantly higher than that of NASAC (23 ± 3 nmol) and NASACS (1079 ± 512 nmol). A possible explanation for this is that amino acids are actively reabsorbed from the urine via several types of transporters in the kidney [42,43]. Moreover, Krause et al. [44] evaluated the chemometrics of SAC metabolization, reporting a higher rate of sulfoxidation of SAC to alliin than N-acetylation of SAC to NASAC. Additionally, possibly because of this, alliin was found in higher concentrations in the urine samples than its metabolites NASAC and NASACS.
Previous studies have reported that garlic intake reduces the amount of N-nitrosoproline (NPRO) excreted, probably related to the presence of NASAC in urine. NPRO formation is used as a biomarker to monitor in vivo nitrosation capacity, a process that has been related to the formation of carcinogenic nitrosamines [45]. Additionally, SAC could be present in urine due to the degradation of more complex molecules such as GSAC, GSACS, alliin or S-(2-carboxypropyl)-L-cysteine, as described by Yamaguchi et al., 2020 [46].
Moreover, Praticò et al. [47] reported a human study in which a significant increase in urinary N-acetyl-S-(2-carboxypropyl)-L-cysteine (NACPC) content was observed after the ingestion of garlic and onion. This compound, considered a biomarker of the consumption of Allium vegetables, is formed by the N-acetylation of S-(2-carboxypropyl)-L-cysteine.
In view of all the information available in the literature and from our results, a potential pathway for the in vivo metabolism of organosulfur compounds in humans is summarized in Figure 3. The parent compound γ-glutamyl-S-(2-carboxypropyl)-L-cysteine-glycine, present in black garlic, can lose glutamic acid or glycine after hydrolysis, forming S-(2-carboxypropyl)-L-cysteine-glycine or γ-glutamyl-S-(2-carboxypropyl)-L-cysteine, respectively. Both compounds could potentially be degraded by hydrolysis to S-(2-carboxypropyl)-L-cysteine, one of the main organosulfur compounds found in urine and a precursor of NACPC, via the N-acetylation reaction.
The Pearson correlation test was performed in the 24 h excretion of the organosulfur compounds after the acute intake of black garlic. The correlation heatmap (Figure 4) showed a strong relationship among most of the organosulfur compounds belonging to the same putative metabolic pathways proposed (Figure 4). The colour indicates the level of correlation: dark orange indicates a strong correlation between the compounds and white indicates no correlation.
According to the metabolic pathway proposed in Figure 3, alliin showed a high correlation with some of its precursors such as γ-glutamyl-S-(2-carboxypropyl)-L-cysteine and S-(2-carboxypropyl)-L-cysteine, as well as with some compounds derived from it such as SAC or the N-acetylated metabolite NASACS.
Similarly, potential degradation pathways for other organosulfur compounds have been proposed as leading to the formation of major compounds excreted in urine such as methiin and deoxypropiin (Figure 5 and Figure 6). Methiin could be formed from the oxidation of GSMC to GSMCS and subsequent hydrolysis releasing glutamic acid, or via the elimination of glutamic acid from GSMC to obtain deoxymethiin and subsequent oxidation (Figure 5). Furthermore, methiin could also be N-acetylated, resulting in N-acetyl-S-methyl-L-cysteine sulfoxide (NASMCS), previously determined in human urine after the consumption of cruciferous vegetables [48], although this compound was not detected in our study. Indeed, methiin and NASCMCS can also be considered biomarkers of allium and cruciferous vegetable consumption by their presence in urine [48].
Moreover, regarding this proposed degradation pathway for γ-glutamyl-S-methyl-L-cysteine-glycine, the heat map (Figure 4) showed a high correlation with its derivatives: methiin, γ-glutamyl-S-methyl-L-cysteine (GSMC) and γ-glutamyl-S-methyl-L-cysteine sulfoxide (GSMCS).
Regarding the significant concentration of deoxypropiin detected in urine, it could be formed after the hydrolysis of γ-glutamyl-S-propyl-L-cysteine-glycine, which releases glycine and γ-glutamyl-S-propyl cysteine (GSPC). GSPC can be oxidised to γ-glutamyl-S-propyl-L-cysteine sulfoxide (GSPCS) or hydrolysed to S-propyl-L-cysteine (deoxypropiin). Both compounds are precursors of S-propyl-L-cysteine sulfoxide (propiin), coming from the hydrolysis of GSPCS and oxidation of deoxypropiin (Figure 6). It is possible that due to the chemical structures of these molecules, N-acetylation reactions of propiin and deoxypropiin could take place. Nevertheless, these metabolic pathways have not been described to date and these compounds have not been found in urine samples from the present study.
Furthermore, the compounds of the putative metabolic pathway in Figure 6 have also shown a high correlation, with deoxypropiin and propiin showing the highest correlation among them, and both showing a significant correlation with its precursor γ-Glutamyl-S-(propyl)-L-cysteine (GSPC).
Finally, methiin and S-(2-carboxypropyl)-L-cysteine showed the highest excretion percentages, accounting for 369.4 and 382.8%, respectively, in relation to the ingested garlic (20 g). This high urine excretion could probably be due to the hydrolysis of precursors of these compounds present in black garlic. In this way, degradation pathways have been proposed in an attempt to explain the obtained results (Figure 3 and Figure 5).
Several studies have related the presence of some of these organosulfur compounds with a potentially beneficial health effect. Alliin has shown antioxidant potential, decreasing or suppressing oxidative stress in rats against liver damage caused by carbon tetrachloride (CCl4) [49].
SAC is also a main organosulfur compound with high biological potential. Several studies have reported that SAC may act as a potential protective agent against neurodegeneration [12]. In a study on Parkinson’s disease, continuous administration of SAC has been shown to significantly decrease lipid peroxidation and the production of reactive oxygen species (ROS) [50]. Furthermore, Ashafaq et al. [51] observed that SAC attenuated oxidative damage and improved neurological deficits in rats with focal cerebral ischaemia.
On the other hand, evidence of potential biological activity of methiin as an antihyperlipidemic, antidiabetic, antimicrobial or antigenotoxic agent has been reported in animal models [52,53]. However, studies reporting on the anticancer potential of methiin are limited, and research is needed to establish the biological activity of this compound in human in vivo studies in the context of diet and disease. The identification of methiin as a urinary biomarker of black garlic consumption may provide an opportunity to further study the anti-cancer potential of this plant secondary metabolite in humans.
Nevertheless, the information available on the physiological transformations of these compounds is still very limited. Fortunately, the identification of these urinary metabolites of organosulfur compounds after the ingestion of black garlic can encourage future studies into the role of this product in human health and further the understanding of the metabolism, tissue distribution and excretion of these compounds.

4. Conclusions

Considering the limited information available, this study aims to identify and quantify the organosulfur compounds excreted in human urine 24 h after the acute intake of black garlic. In total, the excretion of organosulfur compounds 24 h after the ingestion of black garlic was 64,312 ± 26,584 nmol, equivalent to 12.9% of the 498.8 µmol intake of these compounds. More specifically, they consisted of 97.3% SAk derivatives and 2.7% GSAk derivatives. Thirty-three organosulfur compounds were identified and quantified in urine 24 h after ingestion, the predominant ones being methiin (17,954 ± 6040 nmol), isoalliin (15,001 ± 9241 nmol), S-(2-carboxypropyl)-L-cysteine (8804 ± 7220 nmol) and S-propyl-L-cysteine (deoxypropiin) (7035 ± 1392 nmol). Additionally, N-acetyl-S-allyl-L-cysteine (NASAC), N-acetyl-S-allyl-L-cysteine sulfoxide (NASACS) and N-acetyl-S-(2-carboxypropyl)-L-cysteine (NACPC) were detected in the urine samples, these being recognised metabolites of S-allyl-L-cysteine (SAC), alliin and S-(2-carboxypropyl)-L-cysteine, respectively. These compounds are potentially N-acetylated in the liver and kidney, and metabolic degradation pathways have been proposed to explain the presence of the major compounds in urine. The identification of these organosulfur compounds as urinary biomarkers of black garlic ingestion provides opportunities to study the role of this product in human health and also forms the basis for the further evaluation of the biological role and health potential of these secondary plant metabolites in humans.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/antiox12040925/s1, Figure S1: HPLC-HRMS chromatograms of the identified S-Alk(en)yl-L-cysteine derivatives in urine after acute intake of Black Garlic.; Figure S2: HPLC-HRMS chromatograms of the identified γ-Glutamyl-S-alk(en)yl-L-cysteine derivatives in urine after acute intake of Black Garlic.

Author Contributions

Conceptualization, G.P.-C. and J.M.M.-R.; Methodology, G.P.-C., J.M.M.-R., I.A.L. and M.-J.M.; Software, A.M.-O.; Formal Analysis, A.M.-O.; Investigation, A.M.-O., G.P.-C., I.A.L. and M.-J.M.; Resources, J.M.M.-R., I.A.L. and M.-J.M.; Data Curation, A.M.-O.; Writing—Original Draft Preparation, A.M.-O. and G.P.-C.; Writing—Review and Editing, A.M.-O., G.P.-C., J.M.M.-R., I.A.L. and M.-J.M.; Supervision, G.P.-C. and J.M.M.-R.; Project Administration, J.M.M.-R.; Funding Acquisition, J.M.M.-R. All authors have read and agreed to the published version of the manuscript.

Funding

This study was funded by the Andalusian Institute of Agricultural and Fisheries Research and Training (IFAPA), European Social Funds (ESF) and the European Rural Development Fund (ERDF, EU) through Project PP.AVA.AVA2016.20. A. Moreno-Ortega is supported by a postdoctoral fellowship funded by the Spanish Ministry of Science and Innovation (FJC2021-048109-I). G.P.-C. is supported by a postdoctoral research contract “Programa Emergia 2020” funded by the Secretaría General de Universidades, Investigación e Innovación, Junta de Andalucía.

Institutional Review Board Statement

The protocol of the study was approved by the Ethical Committee of the Human Clinical Research Unit at the Arnau Vilanova University Hospital, Lleida, Spain (Approval Number: CEiC-1790).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data are contained within the article.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Amagase, H.; Petesch, B.L. Garlic. In Encyclopedia of Food Sciences and Nutrition; Academic Press: Cambridge, MA, USA, 2003; pp. 2861–2864. [Google Scholar]
  2. Bagul, M.; Kakumanu, S.; Wilson, T.A. Crude Garlic Extract Inhibits Cell Proliferation and Induces Cell Cycle Arrest and Apoptosis of Cancer Cells In Vitro. J. Med. Food 2015, 18, 731–737. [Google Scholar] [CrossRef]
  3. Shin, S.-S.; Song, J.-H.; Hwang, B.; Noh, D.-H.; Park, S.L.; Kim, W.T.; Park, S.-S.; Kim, W.-J.; Moon, S.-K. HSPA6 augments garlic extract-induced inhibition of proliferation, migration, and invasion of bladder cancer EJ cells; Implication for cell cycle dysregulation, signaling pathway alteration, and transcription factor-associated MMP-9 regulation. PLoS ONE 2017, 12, e0171860. [Google Scholar] [CrossRef] [Green Version]
  4. Xu, Y.; Feng, J.; Zhang, D.; Zhang, B.; Luo, M.; Su, D.; Lin, N. S-allylcysteine, a garlic derivative, suppresses proliferation and induces apoptosis in human ovarian cancer cells in vitro. Acta Pharmacol. Sin. 2013, 35, 267–274. [Google Scholar] [CrossRef] [Green Version]
  5. Jang, E.K.; Seo, J.H.; Lee, S.P. Physiological activity and antioxidative effects of aged black garlic (Allium sativum L.) extract. Korean J. Food Sci. Technol. 2008, 40, 443–448. [Google Scholar]
  6. Kang, O.-J. Physicochemical Characteristics of Black Garlic after Different Thermal Processing Steps. Prev. Nutr. Food Sci. 2016, 21, 348. [Google Scholar] [CrossRef] [Green Version]
  7. Kim, J.S.; Kang, O.J.; Gweon, O.C. Comparison of phenolic acids and flavonoids in black garlic at different thermal processing steps. J. Funct. Foods 2013, 5, 80–86. [Google Scholar] [CrossRef]
  8. Ríos-Ríos, K.L.; Montilla, A.; Olano, A.; Villamiel, M. Physicochemical changes and sensorial properties during black garlic elaboration: A review. Trends Food Sci. Technol. 2019, 88, 459–467. [Google Scholar] [CrossRef] [Green Version]
  9. Toledano Medina, M.A.; Pérez-Aparicio, J.; Moreno-Rojas, R.; Merinas-Amo, T. Evolution of some physicochemical and antioxidant properties of black garlic whole bulbs and peeled cloves. Food Chem. 2016, 199, 135–139. [Google Scholar] [CrossRef]
  10. Moreno-Ortega, A.; Pereira-Caro, G.; Ordóñez, J.L.; Moreno-Rojas, R.; Ortíz-Somovilla, V.; Moreno-Rojas, J.M. Bioaccessibility of Bioactive Compounds of ‘Fresh Garlic’ and ‘Black Garlic’ through In Vitro Gastrointestinal Digestion. Foods 2020, 9, 1582. [Google Scholar] [CrossRef]
  11. Ahmed, T.; Wang, C.-K. Black Garlic and Its Bioactive Compounds on Human Health Diseases: A Review. Molecules 2021, 26, 5028. [Google Scholar] [CrossRef]
  12. Gomez, C.D.; Aguilera, P.; Ortiz-Plata, A.; López, F.N.; Chánez-Cárdenas, M.E.; Flores-Alfaro, E.; Ruiz-Tachiquín, M.E.; Espinoza-Rojo, M. Aged garlic extract and S-allylcysteine increase the GLUT3 and GCLC expression levels in cerebral ischemia. Adv. Clin. Exp. Med. 2019, 28, 1609–1614. [Google Scholar] [CrossRef] [PubMed]
  13. Alkreathy, H.M.; AlShehri, N.F.; Kamel, F.O.; Alghamdi, A.K.; Esmat, A.; Karim, S. Aged garlic extract potentiates doxorubicin cytotoxicity in human breast cancer cells. Trop. J. Pharm. Res. 2020, 19, 1669–1676. [Google Scholar] [CrossRef]
  14. Dong, M.; Yang, G.; Liu, H.; Liu, X.; Lin, S.; Sun, D.; Wang, Y. Aged black garlic extract inhibits Ht29 colon cancer cell growth via the PI3K/Akt signaling pathway. Biomed. Reports 2014, 2, 250–254. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Rahman, K.; Billington, D. Dietary Supplementation with Aged Garlic Extract Inhibits ADP-Induced Platelet Aggregation in Humans. J. Nutr. 2000, 130, 2662–2665. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Steiner, M.; Li, W. Aged Garlic Extract, a Modulator of Cardiovascular Risk Factors: A Dose-Finding Study on the Effects of AGE on Platelet Functions. J. Nutr. 2001, 131, 980S–984S. [Google Scholar] [CrossRef] [Green Version]
  17. Wlosinska, M.; Nilsson, A.C.; Hlebowicz, J.; Hauggaard, A.; Kjellin, M.; Fakhro, M.; Lindstedt, S. The effect of aged garlic extract on the atherosclerotic process—A randomized double-blind placebo-controlled trial. BMC Complement. Med. Ther. 2020, 20, 132. [Google Scholar] [CrossRef]
  18. Morihara, N.; Hino, A.; Yamaguchi, T.; Suzuki, J. Aged Garlic Extract Suppresses the Development of Atherosclerosis in Apolipoprotein E–Knockout Mice. J. Nutr. 2016, 146, 460S–463S. [Google Scholar] [CrossRef] [Green Version]
  19. Jeong, J.H.; Jeong, H.R.; Jo, Y.N.; Kim, H.J.; Shin, J.H.; Heo, H.J. Ameliorating effects of aged garlic extracts against Aβ-induced neurotoxicity and cognitive impairment. BMC Complement. Altern. Med. 2013, 13, 1–11. [Google Scholar] [CrossRef] [Green Version]
  20. Shiju, T.; Rajesh, N.; Viswanathan, P. Renoprotective effect of aged garlic extract in streptozotocin-induced diabetic rats. Indian J. Pharmacol. 2013, 45, 23. [Google Scholar] [CrossRef]
  21. Chen, Y.A.; Tsai, J.C.; Cheng, K.C.; Liu, K.F.; Chang, C.K.; Hsieh, C.W. Extracts of black garlic exhibits gastrointestinal motility effect. Food Res. Int. 2018, 107, 102–109. [Google Scholar] [CrossRef]
  22. Moreno-Ortega, A.; Di Pede, G.; Pereira-Caro, G.; Calani, L.; Mena, P.; Del Rio, D.; Moreno-Rojas, J.M. In Vitro Colonic Fermentation of (Poly)phenols and Organosulfur Compounds of Fresh and Black Garlic. J. Agric. Food Chem. 2022, 70, 3666–3677. [Google Scholar] [CrossRef] [PubMed]
  23. Qin, W.; Huber, K.; Popp, M.; Bauer, P.; Buettner, A.; Sharapa, C.; Scheffler, L.; Loos, H.M. Quantification of Allyl Methyl Sulfide, Allyl Methyl Sulfoxide, and Allyl Methyl Sulfone in Human Milk and Urine after Ingestion of Cooked and Roasted Garlic. Front. Nutr. 2020, 7, 565496. [Google Scholar] [CrossRef] [PubMed]
  24. Rosen, R.T.T.; Hiserodt, R.D.; Fukuda, E.K.; Ruiz, R.J.; Zhou, Z.; Lech, J.; Rosen, S.L.; Hartman, T.G. The determination of metabolites of garlic preparations in breath and human plasma. BioFactors 2000, 13, 241–249. [Google Scholar] [CrossRef]
  25. Scheffler, L.; Sharapa, C.; Buettner, A. Quantification of volatile metabolites derived from garlic (Allium sativum) in human urine. Front. Nutr. 2019, 6, 43. [Google Scholar] [CrossRef] [PubMed]
  26. Scheffler, L.; Sharapa, C.; Buettner, A. Quantification of volatile metabolites derived from garlic in human breast milk. Food Chem. 2019, 274, 603–610. [Google Scholar] [CrossRef]
  27. Scheffler, L.; Sauermann, Y.; Heinlein, A.; Sharapa, C.; Buettner, A. Detection of Volatile Metabolites Derived from Garlic (Allium sativum) in Human Urine. Metabolites 2016, 6, 43. [Google Scholar] [CrossRef] [Green Version]
  28. Nagae, S.; Ushijima, M.; Hatono, S.; Imai, J.; Kasuga, S.; Matsuura, H.; Itakura, Y.; Higashi, Y. Pharmacokinetics of the garlic compound S-allylcysteine. Planta Med. 1994, 60, 214–217. [Google Scholar] [CrossRef]
  29. Ichikawa, M.; Mizuno, I.; Yoshida, J.; Ide, N.; Ushijima, M.; Kodera, Y.; Hayama, M.; Ono, K. Pharmacokinetics of cycloalliin, an organosulfur compound found in garlic and onion, in rats. J. Agric. Food Chem. 2006, 54, 9811–9819. [Google Scholar] [CrossRef]
  30. Moreno-Rojas, J.M.; Moreno-Ortega, A.; Ordóñez, J.L.; Moreno-Rojas, R.; Pérez-Aparicio, J.; Pereira-Caro, G. Development and validation of UHPLC-HRMS methodology for the determination of flavonoids, amino acids and organosulfur compounds in black onion, a novel derived product from fresh shallot onions (Allium cepa var. aggregatum). LWT 2018, 97, 376–383. [Google Scholar] [CrossRef]
  31. Kodera, Y.; Suzuki, A.; Imada, O.; Kasuga, S.; Sumioka, I.; Kanezawa, A.; Taru, N.; Fujikawa, M.; Nagae, S.; Masamoto, K.; et al. Physical, chemical, and biological properties of S-allylcysteine, an amino acid derived from garlic. J. Agric. Food Chem. 2002, 50, 622–632. [Google Scholar] [CrossRef]
  32. Chen, Z.; Xu, M.J.; Wang, C.; Zhou, H.; Fan, L.; Huang, X. Thermolysis kinetics and thermal degradation compounds of alliin. Food Chem. 2017, 223, 25–30. [Google Scholar] [CrossRef] [PubMed]
  33. Wang, J.; Cao, Y.; Sun, B.; Wang, C.; Mo, Y. Effect of ultrasound on the activity of alliinase from fresh garlic. Ultrason. Sonochem. 2011, 18, 534–540. [Google Scholar] [CrossRef] [PubMed]
  34. Rahman, M.S. Allicin and Other Functional Active Components in Garlic: Health Benefits and Bioavailability. Int. J. Food Prop. 2007, 10, 245–268. [Google Scholar] [CrossRef]
  35. Marchese, A.; Barbieri, R.; Sanches-Silva, A.; Daglia, M.; Nabavi, S.F.; Jafari, N.J.; Izadi, M.; Ajami, M.; Nabavi, S.M. Antifungal and antibacterial activities of allicin: A review. Trends Food Sci. Technol. 2016, 52, 49–56. [Google Scholar] [CrossRef]
  36. Kodera, Y.; Ushijima, M.; Amano, H.; Suzuki, J.I.; Matsutomo, T. Chemical and Biological Properties of S-1-Propenyl-l-Cysteine in Aged Garlic Extract. Molecules 2017, 22, 570. [Google Scholar] [CrossRef] [Green Version]
  37. Kodera, Y.; Matsutomo, T.; Itoh, K. The Evidence for the Production Mechanism of cis-S-1-Propenylcysteine in Aged Garlic Extract Based on a Model Reaction Approach Using Its Isomers and Deuterated Solvents. Planta Medica Lett. 2015, 2, e69–e72. [Google Scholar] [CrossRef] [Green Version]
  38. Matsutomo, T.; Kodera, Y. Development of an Analytic Method for Sulfur Compounds in Aged Garlic Extract with the Use of a Postcolumn High Performance Liquid Chromatography Method with Sulfur-Specific Detection. J. Nutr. 2016, 146, 450S–455S. [Google Scholar] [CrossRef] [Green Version]
  39. Verhagen, H.; Hageman, G.J.; Rauma, A.-L.; Versluis-de Haan, G.; van Herwijnen, M.H.M.; de Groot, J.; Törrönen, R.; Mykkänen, H. Biomonitoring the intake of garlic via urinary excretion of allyl mercapturic acid. Br. J. Nutr. 2001, 86, S111–S114. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  40. Amano, H.; Kazamori, D.; Itoh, K.; Kodera, Y. Metabolism, Excretion, and Pharmacokinetics of S-Allyl-l-Cysteine in Rats and Dogs. Drug Metab. Dispos. 2015, 43, 749–755. [Google Scholar] [CrossRef] [Green Version]
  41. Munck, L.K.; Munck, B.G. Amino Acid Transport in the Small Intestine. Physiol. Res. 1994, 43, 335–345. [Google Scholar] [CrossRef]
  42. Bröer, S. Amino acid transport across mammalian intestinal and renal epithelia. Physiol. Rev. 2008, 88, 249–286. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Silbernagl, S.; Foulkes, E.C.; Deetjen, P. Renal transport of amino acids. Rev. Physiol. Biochem. Pharmacol. 1975, 74, 105–167. [Google Scholar] [PubMed]
  44. Krause, R.J.; Glocke, S.C.; Elfarra, A.A. Sulfoxides as Urinary Metabolites of S-Allyl-L-Cysteine in Rats: Evidence for the Involvement of Flavin-Containing Monooxygenases. Drug Metab. Dispos. 2002, 30, 1137–1142. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Cope, K.; Seifried, H.; Seifried, R.; Milner, J.; Kris-Etherton, P.; Harrison, E.H. A gas chromatography–mass spectrometry method for the quantitation of N-nitrosoproline and N-acetyl-S-allylcysteine in human urine: Application to a study of the effects of garlic consumption on nitrosation. Anal. Biochem. 2009, 394, 243–248. [Google Scholar] [CrossRef] [Green Version]
  46. Yamaguchi, Y.; Kumagai, H. Characteristics, biosynthesis, decomposition, metabolism and functions of the garlic odour precursor, S-allyl-l-cysteine sulfoxide (Review). Exp. Ther. Med. 2020, 19, 1528–1535. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  47. Praticò, G.; Gao, Q.; Manach, C.; Dragsted, L.O. Biomarkers of food intake for Allium vegetables. Genes Nutr. 2018, 13, 34. [Google Scholar] [CrossRef] [Green Version]
  48. Edmands, W.M.B.; Beckonert, O.P.; Stella, C.; Campbell, A.; Lake, B.G.; Lindon, J.C.; Holmes, E.; Gooderham, N.J. Identification of Human Urinary Biomarkers of Cruciferous Vegetable Consumption by Metabonomic Profiling. J. Proteome Res. 2011, 10, 4513–4521. [Google Scholar] [CrossRef] [Green Version]
  49. Yamaguchi, Y.; Honma, R.; Yazaki, T.; Shibuya, T.; Sakaguchi, T.; Uto-Kondo, H.; Kumagai, H. Sulfuric Odor Precursor S-Allyl-l-Cysteine Sulfoxide in Garlic Induces Detoxifying Enzymes and Prevents Hepatic Injury. Antioxidants 2019, 8, 385. [Google Scholar] [CrossRef]
  50. Rojas, P.; Serrano-García, N.; Medina-Campos, O.N.; Pedraza-Chaverri, J.; Maldonado, P.D.; Ruiz-Sánchez, E. S-Allylcysteine, a garlic compound, protects against oxidative stress in 1-methyl-4-phenylpyridinium-induced parkinsonism in mice. J. Nutr. Biochem. 2011, 22, 937–944. [Google Scholar] [CrossRef]
  51. Ashafaq, M.; Khan, M.M.; Shadab Raza, S.; Ahmad, A.; Khuwaja, G.; Javed, H.; Khan, A.; Islam, F.; Siddiqui, M.S.; Safhi, M.M.; et al. S-allyl cysteine mitigates oxidative damage and improves neurologic deficit in a rat model of focal cerebral ischemia. Nutr. Res. 2012, 32, 133–143. [Google Scholar] [CrossRef]
  52. Komatsu, W.; Miura, Y.; Yagasaki, K. Suppression of hypercholesterolemia in hepatoma-bearing rats by cabbage extract and its component, S-methyl-l-cysteine sulfoxide. Lipids 1998, 33, 499–503. [Google Scholar] [CrossRef] [PubMed]
  53. Marks, H.S.; Anderson, J.A.; Stoewsand, G.S. Effect of s-methyl cysteine sulphoxide and its metabolite methyl methane thiosulphinate, both occurring naturally in brassica vegetables, on mouse genotoxicity. Food Chem. Toxicol. 1993, 31, 491–495. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Chemical structures of organosulfur compounds identified in black garlic in more than 1% of the total organosulfur compounds.
Figure 1. Chemical structures of organosulfur compounds identified in black garlic in more than 1% of the total organosulfur compounds.
Antioxidants 12 00925 g001
Figure 2. Time-course profiles of the organosulfur compounds identified during the urinary excretion after the intake of black garlic. GSAk: γ-Glutamyl-S-alk(en)yl-L-cysteine; SAk: S-alk(en)yl-L-cysteine.
Figure 2. Time-course profiles of the organosulfur compounds identified during the urinary excretion after the intake of black garlic. GSAk: γ-Glutamyl-S-alk(en)yl-L-cysteine; SAk: S-alk(en)yl-L-cysteine.
Antioxidants 12 00925 g002
Figure 3. Potential pathway for the metabolism of γ-glutamyl-S-(2-carboxypropyl)-L-cysteine-glycine in the gastrointestinal tract after black garlic consumption. The proposed metabolism is in keeping with the findings of Yamaguchi et al., 2020, Amano et al., 2015 and Praticò et al., 2018, who monitored the metabolism of SAC in animal species. Boxed compounds indicate the main components excreted in urine after black garlic intake [40,46,47].
Figure 3. Potential pathway for the metabolism of γ-glutamyl-S-(2-carboxypropyl)-L-cysteine-glycine in the gastrointestinal tract after black garlic consumption. The proposed metabolism is in keeping with the findings of Yamaguchi et al., 2020, Amano et al., 2015 and Praticò et al., 2018, who monitored the metabolism of SAC in animal species. Boxed compounds indicate the main components excreted in urine after black garlic intake [40,46,47].
Antioxidants 12 00925 g003
Figure 4. Correlation Heat Map based on Pearson correlation (p < 0.05). The colour indicates the level of correlation: dark orange indicates a strong correlation between the compounds and white indicates no correlation. GSPCS: γ-Glutamyl-S-(propyl)-L-cysteine sulfoxide; GSMC: γ-Glutamyl-S-methyl-L-cysteine; GSAC: γ-Glutamyl-S-allyl-L-cysteine; GS1PCS: γ-Glutamyl-S-(1-propenyl)-L-cysteine sulfoxide; GSACS: γ-Glutamyl-S-allyl-L-cysteine sulfoxide: GSMCS: γ-Glutamyl-S-methyl-L-cysteine sulfoxide; GSPC: γ-Glutamyl-S-(propyl)-L-cysteine; NASACS: N-Acetyl-S-allyl-L-cysteine sulfoxide; SAC: S-Allyl-L-cysteine; NASAC: N-Acetyl-S-allyl-L-cysteine; S1PC: trans-S-(1-Propenyl)-L-cysteine; NACPC: N-Acetyl-S-(2-carboxypropyl)-L-cysteine;.
Figure 4. Correlation Heat Map based on Pearson correlation (p < 0.05). The colour indicates the level of correlation: dark orange indicates a strong correlation between the compounds and white indicates no correlation. GSPCS: γ-Glutamyl-S-(propyl)-L-cysteine sulfoxide; GSMC: γ-Glutamyl-S-methyl-L-cysteine; GSAC: γ-Glutamyl-S-allyl-L-cysteine; GS1PCS: γ-Glutamyl-S-(1-propenyl)-L-cysteine sulfoxide; GSACS: γ-Glutamyl-S-allyl-L-cysteine sulfoxide: GSMCS: γ-Glutamyl-S-methyl-L-cysteine sulfoxide; GSPC: γ-Glutamyl-S-(propyl)-L-cysteine; NASACS: N-Acetyl-S-allyl-L-cysteine sulfoxide; SAC: S-Allyl-L-cysteine; NASAC: N-Acetyl-S-allyl-L-cysteine; S1PC: trans-S-(1-Propenyl)-L-cysteine; NACPC: N-Acetyl-S-(2-carboxypropyl)-L-cysteine;.
Antioxidants 12 00925 g004
Figure 5. Degradation pathway proposed of γ-Glutamyl-S-methyl-L-cysteine-glycine based on the reports of Edmands et al., 2011 [48]. Boxes with compounds indicate the main components excreted in urine after black garlic intake.
Figure 5. Degradation pathway proposed of γ-Glutamyl-S-methyl-L-cysteine-glycine based on the reports of Edmands et al., 2011 [48]. Boxes with compounds indicate the main components excreted in urine after black garlic intake.
Antioxidants 12 00925 g005
Figure 6. Degradation pathway proposed for γ-glutamyl-S-propyl cysteine-glycine. Boxes with compounds indicate the main components excreted in urine after black garlic intake.
Figure 6. Degradation pathway proposed for γ-glutamyl-S-propyl cysteine-glycine. Boxes with compounds indicate the main components excreted in urine after black garlic intake.
Antioxidants 12 00925 g006
Table 1. Organosulfur compounds identified and quantified in 20 g of black garlic expressed as mean ± SD.
Table 1. Organosulfur compounds identified and quantified in 20 g of black garlic expressed as mean ± SD.
Black Garlicµmol% in Black Garlic
γ-Glutamyl-S-alk(en)yl-L-cysteine derivatives (GSAk)
γ–Glutamyl-S-propyl-L-cysteine sulfoxide (GSPCS)0.86 ± 0.070.2
γ-Glutamyl-S-(2-carboxypropyl)-L-cysteine1.00 ± 0.070.2
γ-Glutamyl-S-methyl-L-cysteine (GSMC)3.98 ± 0.000.8
γ-Glutamyl-S-allyl-L-cysteine (GSAC)87.9 ± 0.417.2
γ-Glutamyl-S-allyl-L-cysteine sulfoxide (GSACS)69.0 ± 0.313.5
γ-Glutamyl-S-methyl-L-cysteine sulfoxide (GSMCS)7.60 ± 0.021.5
γ–Glutamyl-S-propyl-L-cysteine (GSPC)0.90 ± 0.080.2
γ-Glutamyl-S-(2-carboxyethyl)-L-cysteine-glycine2.38 ± 0.010.5
γ-Glutamyl-S-allylthio-L-cysteine10.08 ± 0.022.0
γ-Glutamyl-S-(2-carboxypropyl)-L-cysteine-glycine3.03 ± 0.210.6
Total GSAk186.7 ± 0.736.6
S-alk(en)yl-L-cysteine derivatives (SAk)
S-Allyl-L-cysteine (SAC)153.7 ± 0.330.1
S-Allyl-L-cysteine sulfoxide (Alliin)112.2 ± 0.622
S-(2-Carboxypropyl)-L-cysteine2.30 ± 0.000.5
S-Methyl-L-cysteine sulfoxide (Methiin)4.86 ± 0.031.0
Methionine sulfoxide10.04 ± 0.032.0
S-(2-carboxypropyl)-L-cysteine-glycine5.20 ± 0.221.0
S-Methyl-L-cysteine (Deoxymethiin)3.36 ± 0.020.7
S-Allylmercapto-L-cysteine (SAMC)8.16 ± 0.021.6
S-Propylmercapto-L-cysteine (SPMC)4.58 ± 0.010.9
S-Allylsulfenic acid18.70 ± 0.053.7
Total SAk323.1 ± 0.963.4
Total Organosulfur Compounds509.8 ± 1.6100
Table 2. UHPLC-HRMS-based identification of organosulfur compounds detected in human urine samples after acute intake of 20 g of black garlic.
Table 2. UHPLC-HRMS-based identification of organosulfur compounds detected in human urine samples after acute intake of 20 g of black garlic.
PeakRetention Time (min)CompoundChemical Formula [m/z]-Experimental Mass [m/z]-δ (ppm)
γ-Glutamyl-S-alk(en)yl-L-cysteine derivatives (GSAk)
14.34γ-Glutamyl-S-(propyl)-L-cysteine sulfoxide (GSPCS)C11H21N2O6S309.1115−2.1191
26.34γ-Glutamyl-S-(S-1-propenyl)-L-cysteine-glycineC13H22N3O6S2380.09440.8362
36.43γ-Glutamyl-S-(2-carboxypropyl)-L-cysteineC12H19N2O7S−2335.0907−0.0579
47.86γ-Glutamyl-S-(S-methyl)-L-cysteine-glycineC11H20N3O6S2354.07880.6916
57.88γ-Glutamyl-S-methyl-L-cysteine (GSMC)C9H17N2O5S265.08530.1777
68.53GlutathioneC10H18N3O6S308.09110.7967
78.55γ-Glutamyl-S-allyl-L-cysteine (GSAC)C11H19N2O5S291.10090.4285
88.71γ-Glutamyl-L-cysteineC8H15N2O5S251.0696−0.9444
98.75γ-Glutamyl-S-(1-propenyl)-L-cysteine sulfoxide (GS1PCS)C11H19N2O6S307.0958−0.4247
109.00γ-Glutamyl-S-allyl-L-cysteine sulfoxide (GSACS)C11H19N2O6S307.0958−1.0128
119.61γ-Glutamyl-S-methyl-L-cysteine sulfoxide (GSMCS)C9H17N2O6S281.0801−0.8092
129.63γ-Glutamyl-S-(propyl)-L-cysteine (GSPC)C11H21N2O5S293.1165−0.3883
S-alk(en)yl-L-cysteine derivatives (SAk)
131.39S-(2-Propenyl)-allyl-L-cysteine sulfoxideC9H16NO3S218.0845−1.8770
143.92N-Acetyl-S-allyl-L-cysteine sulfoxide (NASACS)C8H14NO4S220.0638−1.2877
153.96S-Butanoyl-L-cysteine sulfoxide (Butiin)C7H16NO3S194.0845−0.8589
164.00S-Allyl-L-cysteine (SAC)C6H12NO2S162.0583−1.0605
174.21N-Acetyl-S-allyl-L-cysteine (NASAC)C8H14NO3S204.0689−1.9576
184.97trans-S-(1-Propenyl)-L-cysteine (S1PC)C6H12NO2S162.0583−0.5898
195.60S-Propyl-L-cysteine (Deoxypropiin)C6H14NO2S164.0740−4.2089
206.18S-Allyl-L-cysteine sulfoxide (Alliin)C6H12NO3S178.05321.5374
216.70S-(1-Propenyl)-L-cysteine sulfoxide (Isoalliin)C6H12NO3S178.05322.5793
227.10CycloalliinC6H12NO3S178.05322.3222
237.13S-(2-Carboxypropyl)-L-cysteineC7H14NO4S208.06381.7404
247.26S-Methyl-L-cysteine sulfoxide (Methiin)C4H10NO3S152.03763.5869
257.56Methionine sulfoxideC5H12NO3S166.0532−0.6264
267.87S-Propyl-L-cysteine sulfoxide (Propiin)C6H14NO3S180.06892.4960
278.09S-Carboxymethyl-L-cysteine (Carbocysteine)C5H10NO4S180.03252.5441
288.43S-(2-Carboxypropyl)-L-cysteine-glycineC9H17N2O5S265.08530.6382
298.55S-Ethyl-L-cysteine sulfoxide (Ethiin)C5H12NO3S166.0532−0.0752
309.50AjoeneC9H15OS3235.0280−1.1224
319.58N-Acetyl-S-(2-carboxypropyl)-L-cysteine (NACPC)C9H16NO5S250.07442.5686
329.74S-AllylmercaptoglutathioneC13H22N3O6S2380.09450.2443
3310.89AllixinC12H19O4227.1278−1.6378
Table 3. Time-course profiles of the organosulfur compounds identified during urinary excretion after the intake of black garlic.
Table 3. Time-course profiles of the organosulfur compounds identified during urinary excretion after the intake of black garlic.
PeakCompounds (nmol)0–2 h2–4 h4–8 h8–24 h0–24 h% Excretion
γ-Glutamyl-S-alk(en)yl-L-cysteine derivatives (GSAk)
1γ-Glutamyl-S-(propyl)-L-cysteine sulfoxide99 ± 0 a48 ± 12 a87 ± 19 a88 ± 28 a323 ± 5937.6
2γ-Glutamyl-S-(S-1-propenyl)-L-cysteine-glycine1.6 ± 0.2 c1.0 ± 0.0 bc6.9 ± 0.0 a2.5 ± 0.0 b12.1 ± 0.2-
3γ-Glutamyl-S-(2-carboxypropyl)-L-cysteine15 ± 3 a10 ± 3 a14 ± 2 a27 ± 11 a66 ± 196.6
4γ-Glutamyl-S-(S-methyl)-L-cysteine-glycine29 ± 4 b22 ± 4 b47 ± 7 b157 ± 25 a255 ± 40-
5γ-Glutamyl-S-methyl-L-cysteine (GSMC)60 ± 11 b37 ± 4 b101 ± 24 b371 ± 65 a568 ± 10414.3
6Glutathione21 ± 3 b10 ± 2 b31 ± 5 ab60 ± 13 a122 ± 22-
7γ-Glutamyl-S-allyl-L-cysteine (GSAC)19 ± 5 b11 ± 2 b17 ± 4 b42 ± 9 a89 ± 200.1
8γ-Glutamyl-L-cysteine37 ± 8 b18 ± 3 b41 ± 11 ab89 ± 18 a185 ± 40-
9γ-Glutamyl S-(1-propenyl)-L-cysteine sulfoxide (GS1PCS)3.1 ± 0.4 a1.1 ± 0.3 a1.7 ± 0.2 a3.2 ± 0.1 a9.1 ± 1.0-
10γ-Glutamyl-S-allyl-L-cysteine sulfoxide (GSACS)13 ± 3 ab8 ± 1 b13 ± 3 ab24 ± 4 a58 ± 110.08
11γ-Glutamyl-S-methyl-L-cysteine sulfoxide (GSMCS)43 ± 12 b29 ± 9 b69 ± 25 b166 ± 35 a308 ± 824.05
12γ-Glutamyl-S-(propyl)-L-cysteine17 ± 3 b8 ± 1 b14 ± 4 b37 ± 7 a76 ± 158.4
Total GSAk251 ± 41 b144 ± 21 b339 ± 77 b980 ± 134 a1713 ± 2730.92
S-alk(en)yl-L-cysteine derivatives (SAk)
13S-(2-Propenyl)-allyl-L-cysteine sulfoxide179 ± 37 a98 ± 23 a162 ± 90 a238 ± 69 a678 ± 220-
14N-acetyl-S-allyl-L-cysteine sulfoxide (NASACS)144 ± 35 a118 ± 45 a144 ± 40 a672 ± 391 a1079 ± 512-
15S-Butanoyl-L-cysteine sulfoxide (Butiin)17 ± 3 a34 ± 16 a14 ± 3 a94 ± 28 a159 ± 50-
16S-Allyl-L-cysteine (SAC)302 ± 64 b348 ± 112 b391 ± 73 ab1950 ± 810 a2991 ± 10591.95
17N-acetyl-S-allyl-L-cysteine (NASAC)1.49 ± 0.00 a10 ± 2 a3.4 ± 0.1 a8.6 ± 1.7 a23 ± 3-
18tranS-S-(1-Propenyl)-L-cysteine (S1PC)618 ± 27 a982 ± 151 a448 ± 78 a1862 ± 731 a3911 ± 987-
19S-Propyl-L-cysteine (Deoxypropiin)1417 ± 201 b1005 ± 106 b1387 ± 406 b3226 ± 679 a7035 ± 1392-
20S-Allyl-L-cysteine sulfoxide (Alliin)97 ± 15 a144 ± 35 a105 ± 25 a1037 ± 961 a1383 ± 10351.23
21traN-S-(1-Propenyl)-L-cysteine sulfoxide (Isoalliin)1825 ± 629 a2483 ± 704 a2059 ± 634 a8633 ± 7274 a15,001 ± 9241-
22Cycloalliin120 ± 18 ab244 ± 42 a198 ± 47 a63 ± 15 b625 ± 122-
23S-(2-Carboxypropyl)-L-cysteine382 ± 59 a275 ± 45 a389 ± 78 a7759 ± 7038 a8804 ± 7220382.8
24S-Methyl-L-cysteine sulfoxide (Methiin)2854 ± 7632203 ± 5183596 ± 12059300 ± 355417,954 ± 6040369.4
25Methionine sulfoxide237 ± 29 b387 ± 61 b567 ± 94 b1029 ± 159 a2221 ± 34322.1
26S-Propyl-L-cysteine sulfoxide (Propiin)165 ± 35 b131 ± 21 b196 ± 26 b533 ± 106 a1024 ± 189-
27S-Carboxymethyl-L-cysteine (Carbocysteine)59 ± 8 b61 ± 9 b94 ± 19 b222 ± 41 a435 ± 78-
28S-(2-Carboxypropyl)-L-cysteine-glycine232 ± 79 ab89 ± 22 b248 ± 77 ab472 ± 85 a1041 ± 26420.0
29S-Ethyl-L-cysteine sulfoxide (Ethiin)65 ± 16 b42 ± 8 b98 ± 27 b229 ± 35 a435 ± 86-
30Ajoene6.6 ± 1.4 b5.3 ± 0.8 b12 ± 2 b31 ± 7 a55 ± 11-
31N-acetyl-S-(2-carboxypropyl)-L-cysteine (NACPC)37 ± 5 b19 ± 2 b57 ± 8 ab80 ± 11 a193 ± 27-
32S-Allylmercaptoglutathione1.8 ± 0.4 b<LOD1.5 ± 0.1 b5.0 ± 0.3 a8.3 ± 0.8-
33Allixin<LOD13 ± 4 a19 ± 1 a9.5 ± 2.a41 ± 8-
Total SAk8200 ± 16057810 ± 15069802 ± 261936,787 ± 20,67362,599 ± 26,40319.4
Total Organosulfur Compounds8451 ± 16307953 ± 151810,141 ± 269037,767 ± 20,74664,312 ± 26,58412.6
Results are expressed as mean ± SE (standard error). LOD: Limit of Detection; Different letters (one-way ANOVA) denote significant differences (p < 0.05) among the stages (0–2 h; 2–4 h;4–8 h; 8–24 h) for the same compound.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Moreno-Ortega, A.; Pereira-Caro, G.; Ludwig, I.A.; Motilva, M.-J.; Moreno-Rojas, J.M. Bioavailability of Organosulfur Compounds after the Ingestion of Black Garlic by Healthy Humans. Antioxidants 2023, 12, 925. https://doi.org/10.3390/antiox12040925

AMA Style

Moreno-Ortega A, Pereira-Caro G, Ludwig IA, Motilva M-J, Moreno-Rojas JM. Bioavailability of Organosulfur Compounds after the Ingestion of Black Garlic by Healthy Humans. Antioxidants. 2023; 12(4):925. https://doi.org/10.3390/antiox12040925

Chicago/Turabian Style

Moreno-Ortega, Alicia, Gema Pereira-Caro, Iziar A. Ludwig, María-José Motilva, and José Manuel Moreno-Rojas. 2023. "Bioavailability of Organosulfur Compounds after the Ingestion of Black Garlic by Healthy Humans" Antioxidants 12, no. 4: 925. https://doi.org/10.3390/antiox12040925

APA Style

Moreno-Ortega, A., Pereira-Caro, G., Ludwig, I. A., Motilva, M. -J., & Moreno-Rojas, J. M. (2023). Bioavailability of Organosulfur Compounds after the Ingestion of Black Garlic by Healthy Humans. Antioxidants, 12(4), 925. https://doi.org/10.3390/antiox12040925

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop